According to the Legislative Budget Board (LBB), HB 50 will have no significant fiscal impact on the state of Texas. The legislation includes a provision stipulating that the Health and Human Services Commission (HHSC) is required to carry out the bill's directives only if the legislature specifically appropriates funds for that purpose. If no specific appropriation is made, HHSC has discretion to implement the provisions using other available resources, but is not obligated to do so.

Additionally, if HHSC chooses not to implement the bill due to a lack of funding in a given fiscal year, it must report that fact in its next legislative budget request. The report must also include cost estimates for implementing the bill in each year of the upcoming state fiscal biennium. This mechanism provides a pathway for delayed implementation without requiring immediate state expenditure.

From a local government perspective, the bill is also not expected to have a significant fiscal impact on cities, counties, or other local governmental entities. Overall, the fiscal note assumes that any costs incurred by state agencies under the provisions of the bill could be absorbed within existing resources, suggesting that the bill has been crafted with budget-conscious flexibility in mind.

HB 50 is a well-intentioned proposal that seeks to address the rise in undiagnosed HIV and other sexually transmitted infections in Texas through earlier detection and improved access to health information. The bill requires health care providers to submit blood samples for an HIV screening as part of a medical STD screening unless the patient explicitly opts out, and mandates patient notification and access to support services if the test is positive. It also provides a measured implementation timeline and ties enforcement to legislative appropriations, helping manage fiscal and administrative impact. As currently written, the bill respects informed consent through an opt-out approach and does not impose significant costs on taxpayers or local governments​.

However, for those who prioritize individual liberty and informed medical decision-making, the opt-out model may not go far enough in affirming active patient autonomy. While the bill does require providers to inform patients of their right to decline, the default nature of opt-out consent can lead to confusion or passive compliance, particularly in fast-paced or high-volume medical settings. Shifting the bill to an opt-in framework, where testing only occurs after a patient has clearly and affirmatively agreed, would enhance clarity, strengthen patient trust, and reinforce the principle of voluntary medical participation, especially in matters as sensitive as HIV testing.

Additionally, while the bill avoids new taxes or mandatory spending, it does expand HHSC’s rulemaking authority and regulatory scope. This modest growth in government oversight is justified by public health concerns but should be tightly defined to prevent future overreach. An amendment that limits discretionary authority and ensures uniform, clearly communicated opt-in consent procedures would bring the bill into better alignment with both public health goals and foundational liberty principles.

As such, Texas Policy Research recommends that lawmakers vote YES on HB 50 but also suggests the bill be amended as described above to respect individual liberty and informed medical decision-making.

• Individual Liberty: The bill supports individual liberty by requiring that patients be informed and given the chance to decline testing (opt-out). This is a significant improvement over silent or assumed testing policies and respects the basic right to bodily autonomy. However, because it defaults to testing unless declined, it may fall short of full active consent, especially for those who view medical decisions as requiring an explicit “yes” (opt-in).
• Personal Responsibility: The bill encourages early detection of HIV, which can prevent further transmission and lead to earlier treatment. This promotes personal health accountability and equips individuals with knowledge that helps them act responsibly, both for themselves and others. By requiring providers to connect patients to resources after a positive result, it reinforces a system where individuals take informed action.
• Free Enterprise: The bill doesn’t interfere with private markets or restrict entry into healthcare professions. However, it does add a layer of compliance for healthcare providers, especially in how they handle consent, testing, and follow-up. While not a significant regulatory burden, small clinics might feel this more than large systems.
• Private Property Rights: The bill doesn’t impact land or traditional property rights. But if you extend the idea of “property” to include bodily autonomy, then the requirement for default testing (even with opt-out) does nudge against the principle that each individual fully owns and controls their own body.
• Limited Government: The bill moderately expands government scope by creating new responsibilities for HHSC and authorizing rulemaking. It does not mandate implementation unless funded, which preserves some fiscal restraint. But the broad discretion given to HHSC and the delayed full enforcement date (2029) could allow for bureaucratic drift or inconsistent application.

• HB 4147 (Same As)
• SB 2916 (Same As)